NCT06335576View on ClinicalTrials.gov

Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application

Not yet recruitingOBSERVATIONAL
Enrollment

89

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Gastric Cancer
Interventions
OTHER

This study is a single-arm and observational study with no intervention.

This study is a single-arm and observational study with no intervention.

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT06335576 - Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application | Biotech Hunter | Biotech Hunter